Orthopedics News |
|
|
 | 11/17/2009
New Cause Of Osteoporosis: Mutation In A MiroRNA
Many biological processes are controlled by small molecules known as microRNAs, which work by suppressing the expression of specific sets of genes. Xiang-Hang Luo and colleagues, at Second Xiangya Hos...
Source: Journal of Clinical Investigation |
|
11/12/2009
Bone Scintigraphy Quantifies Knee Osteoarthritis
In patients with knee osteoarthritis. bone scintigraphic abnormalities are strongly associated with knee malalignment and pain, North Carolina-based researchers report in the November issue of the Ann...
Source: Reuters Health |
11/10/2009
ApaTech® Launches the Actifuse® MIS Bone Graft Delivery System: Reaching New Levels in Synthetic Bone Grafting
ApaTech, the rapidly growing orthobiologics company, announces the global launch of the Actifuse® MIS Bone Graft Delivery System, a revolutionary addition to the Company's product line....
Source: ApaTech |
11/10/2009
FDA-Approved Drugs Eliminate, Prevent Cervical Cancer In Mice
Researchers at the University of Wisconsin-Madison School of Medicine and Public Health have eliminated cervical cancer in mice with two FDA-approved drugs currently used to treat breast cancer and os...
Source: University of Wisconsin-Madison |
11/10/2009
Connection Between Depression And Osteoporosis Detailed By Hebrew University Researchers
Jerusalem, Nov. 9, 2009 – Research carried out among thousands of people has shown a clear connection between depression and a loss of bone mass, leading to osteoporosis and fractures....
Source: The Hebrew University of Jerusalem |
11/9/2009
Risk Of Hip Fracture In Postmenopausal Women Rises Steeply With Age
Among postmenopausal women, the risk of hip fractures increases steeply with age and is seven times higher in 70-year olds than in 50- year olds, according to a study in this week's...
Source: Public Library of Science |
11/4/2009
New Study Further Disputes Notion That Amputee Runners Gain Advantage From Protheses
A study by six researchers, including a University of Colorado at Boulder associate professor and his former doctoral student, shows that amputees who use running-specific prosthetic legs have no perf...
Source: University of Colorado at Boulder |
11/3/2009
Nation's Hip Fracture Rate Could Drop 25 Percent With Aggressive Osteoporosis Prevention
November 2, 2009 (Downey, Calif.) – Aggressively managing patients at risk for osteoporosis could reduce the hip fracture rate in the United States by 25 percent, according to a Kaiser Permanente stud...
Source: Kaiser Permanente |
11/3/2009
New Study Finds Shock-Wave Therapy for Unhealed Fractured Bones
ROSEMONT, Ill – When fractured bones fail to heal, a serious complication referred to as "nonunion" can develop. This occurs when the process of bone healing is interrupted or stalled. According to a...
Source: American Academy of Orthopaedic Surgeons |
11/3/2009
Mending Meniscalsin Children, Improving Diagnosis and Recovery
The meniscus is a rubber-like, crescent moon-shaped cartilage cushion that sits between the leg and thigh bone. Each knee has two menisci: one on the inside of the knee joint and one on the outside. I...
Source: American Academy of Orthopaedic Surgeons |
11/3/2009
Study Finds Link Between Childhood Physical Abuse and Arthritis
Adults who had experienced physical abuse as children have 56 per cent higher odds of osteoarthritis compared to those who have not been abused, according to a new study by University of Toronto resea...
Source: University of Toronto |
11/3/2009
Developmental Drug May Help Bone Fractures Heal After Radiation Exposure
A drug currently under development by the University of Pittsburgh School of Medicine may help bone fractures heal more quickly after radiation exposure, according to a study by Pitt researchers. The...
Source: University of Pittsburgh Schools of the Health Sciences |
10/29/2009
Health Alliance Announces Promising Nine-Month Results from First Ever Outcome-Based Reimbursement Program for Actonel® (risedronate sodium) Tablets
Health Alliance Medical Plans, Inc., a leading provider-sponsored health insurer, covering more than 310,000 commercial plan members in Illinois and Iowa, has announced positive outcomes from a nine-m...
Source: Health Alliance Medical Plans, Inc. |
10/29/2009
Pain Thresholds Linked to Inflammation and Sleep Problems in Arthritis Patients
Despite recent advances in anti-inflammatory therapy, many rheumatoid arthritis (RA) patients continue to suffer from pain. Research published in BioMed Central's open access journal, Arthritis Resear...
Source: BioMed Central |
10/29/2009
Research Shows Tai Chi Exercise Reduces Knee Osteoarthritis Pain in the Elderly
Researchers from Tufts University School of Medicine have determined that patients over 65 years of age with knee osteoarthritis (OA) who engage in regular Tai Chi exercise improve physical function a...
Source: Wiley-Blackwell |
10/29/2009
Teriparatide Outperforms Alendronate in Treating Steroid-Induced Osteoporosis
A recent study determined glucocorticoid-induced osteoporosis (OP) is now treatable with Teriparatide, a synthetic form of the human parathyroid hormone. Researchers found patients with glucocorticoid...
Source: Wiley-Blackwell |
10/27/2009
Short-Term, High-Dose Vitamin D2 May Ease Deficiency
Researchers are reporting that eight weeks of treatment with large doses of vitamin D2 can eliminate vitamin D deficiency, and twice-monthly doses can keep the condition at bay for up to six years....
Source: HealthDay News |
10/25/2009
Oklahoma Scientists Discover Promising New Path for Treating Traumas
A discovery by scientists at the Oklahoma Medical Research Foundation could help save lives threatened by traumatic injuries like those sustained in car crashes or on the battlefield. The work also ho...
Source: Oklahoma Medical Research Foundation |
10/23/2009
ACR: Tanezumab Keeps OA Knee Pain Under Control
Patients who were treated with tanezumab, an investigational monoclonal antibody against nerve growth factor, had relief of osteoarthritis knee pain over the course of a year, researchers said here....
Source: medpageToday |
10/22/2009
TNF-Alpha Inhibitors Will Continue to Dominate First- and Second-Line Biologic Therapy for the Treatment of Rheumatoid Arthritis Through 2011
Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that tumor necrosis factor (TNF)-alpha inhibitors will continue to do...
Source: Decision Resources |
 |
| Next Page |
|
